1. Home
  2. GRFS vs AMG Comparison

GRFS vs AMG Comparison

Compare GRFS & AMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • AMG
  • Stock Information
  • Founded
  • GRFS 1940
  • AMG 1993
  • Country
  • GRFS Spain
  • AMG United States
  • Employees
  • GRFS N/A
  • AMG N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • AMG Investment Managers
  • Sector
  • GRFS Health Care
  • AMG Finance
  • Exchange
  • GRFS Nasdaq
  • AMG Nasdaq
  • Market Cap
  • GRFS 7.2B
  • AMG 5.9B
  • IPO Year
  • GRFS 2006
  • AMG 1997
  • Fundamental
  • Price
  • GRFS $10.72
  • AMG $218.82
  • Analyst Decision
  • GRFS Hold
  • AMG Strong Buy
  • Analyst Count
  • GRFS 1
  • AMG 5
  • Target Price
  • GRFS $10.30
  • AMG $228.00
  • AVG Volume (30 Days)
  • GRFS 1.3M
  • AMG 166.7K
  • Earning Date
  • GRFS 01-01-0001
  • AMG 07-31-2025
  • Dividend Yield
  • GRFS 1.33%
  • AMG 0.02%
  • EPS Growth
  • GRFS 132.60
  • AMG N/A
  • EPS
  • GRFS 0.53
  • AMG 13.84
  • Revenue
  • GRFS $8,744,226,659.00
  • AMG $2,030,400,000.00
  • Revenue This Year
  • GRFS $5.40
  • AMG $2.90
  • Revenue Next Year
  • GRFS $6.74
  • AMG $4.90
  • P/E Ratio
  • GRFS $25.84
  • AMG $15.80
  • Revenue Growth
  • GRFS 9.32
  • AMG 0.11
  • 52 Week Low
  • GRFS $6.19
  • AMG $139.22
  • 52 Week High
  • GRFS $11.14
  • AMG $224.30
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 66.35
  • AMG 61.35
  • Support Level
  • GRFS $10.40
  • AMG $208.34
  • Resistance Level
  • GRFS $10.84
  • AMG $224.30
  • Average True Range (ATR)
  • GRFS 0.32
  • AMG 5.55
  • MACD
  • GRFS -0.04
  • AMG 0.26
  • Stochastic Oscillator
  • GRFS 73.91
  • AMG 77.43

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About AMG Affiliated Managers Group Inc.

Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of March 2025, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 20% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (22%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (58%)—had $712 billion in managed assets.

Share on Social Networks: